Galileo - Biotech Innovation Fund IM Fonds
123,89
USD
+0,64
USD
+0,52
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Arcellx Inc | US03940C1009 | 8,80% |
| Krystal Biotech Inc | US5011471027 | 7,24% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 7,01% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 5,08% |
| BioNTech SE ADR | US09075V1026 | 4,68% |
| Stoke Therapeutics Inc | US86150R1077 | 4,58% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,43% |
| CARsgen Therapeutics Holdings Ltd Ordinary Shares | KYG1996C1006 | 3,33% |
| CRISPR Therapeutics AG | CH0334081137 | 3,20% |
| Gilead Sciences Inc | US3755581036 | 3,16% |
| Sonstige | 49,49% |